Olema Pharmaceuticals $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Precigen $79 million preferred stock and warrants offering
We advised Precigen on the private placement
Personalis $50 million at-the-market offering
The shares are listed on the Nasdaq Global Market
Revolution Medicines $750 million stock and pre-funded warrants offering
The stock is listed on the Nasdaq Global Select Market
Laekna HK$236 million placement of shares
We advised Laekna on the placement of new shares
Alignment Healthcare $330 million convertible senior notes offering
The convertible notes are due 2029
ACELYRIN $150 million at-the-market offering
The shares are listed on the Nasdaq Global Select Market
Cardinal Health $2.9 billion notes offering
The investment-grade notes are due 2026, 2029, 2034 and 2054
Omnicell $172.5 million convertible senior notes offering
The convertible senior notes are due 2029
Horizon Mutual Holdings debut $600 million senior notes offering
The investment-grade notes are due 2034